0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Phototherapies for Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Phototherapies for Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Generalized pustular psoriasis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Generalized pustular psoriasis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Psoriasis Vulgaris - Epidemiology Forecast to 2032 - Product Thumbnail Image

Psoriasis Vulgaris - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$3,750USDGBP
From
EUR$7,950USDGBP
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
EUR$2,250USDGBP
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
EUR$2,000USDGBP
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$4,950USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
EUR$4,949USDGBP
From
EUR$4,949USDGBP
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
EUR$4,949USDGBP
Generalized Pustular Psoriasis (GPP) - Competitive Landscape - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Competitive Landscape

  • Report
  • December 2023
  • 78 Pages
  • Global
From
EUR$3,495USDGBP
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more